Sun Builds On Psoriasis Data But Can It Hold In Crowded Space?

Marathon runners
Sun Pharma's tildrakizumab faces a crowded competitive space • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D